ArticleCirculation2023
Regulation of Postnatal Cardiomyocyte Maturation by an RNA Splicing Regulator RBFox1.
Open access · greenAbstract read
In one paragraph
Article in Circulation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 14 citations in OpenAlex.
- Digital Light Processing 3D Printing Enables Versatile Fabrication of Human Engineered Heart Tissues.Cell biomaterials · 2026Article
- Spatiotemporal transcriptomics of human cardiovascular progenitors in pig hearts identifies Midkine as a positive regulator of neovascularization.Nature cardiovascular research · 2026Article
- Transcriptional regulation in heart development, disease and regeneration: reassessing the fetal gene hypothesis.Nature reviews. Cardiology · 2026Review
- Cardioprotective role of RBFox1 in myocardial infarction-induced heart failure.Cardiovascular research · 2025Article
- Decoding Cardiac Maturation Program: Insights from RNA Splicing Regulation.Current cardiology reports · 2025Review
- Tumour initiated purinergic signalling promotes cardiomyocyte RBFOX1 degradation and cardiotoxicity from DNA damaging anticancer agents.Nature communications · 2025Article
- DDX1 methylation mediated MATR3 splicing regulates intervertebral disc degeneration by initiating chromatin reprogramming.Nature communications · 2025Article
- Seeing is Believing: Muscleblind-like 1 Is Necessary For Mammalian Cardiomyocyte Maturation.Circulation · 2024Article
- RNA-Binding Proteins in Cardiomyopathies.Journal of cardiovascular development and disease · 2024Review
- Cardiomyocyte Maturation: New Phase in Development.Circulation research · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors at 10 institutions in 4 countries.
Jijun Huang *Cardiovascular Laboratory, Division of Molecular Medicine, Department of Anesthesiology and Perioperative Medicine (J.H., J.Z.L., C.D.R., T.Y., T.K.K., C.G., Y.W.), University of California, Los Angeles.ORCID 0000-0002-5520-193X
Josh Z Lee *Cardiovascular Laboratory, Division of Molecular Medicine, Department of Anesthesiology and Perioperative Medicine (J.H., J.Z.L., C.D.R., T.Y., T.K.K., C.G., Y.W.), University of California, Los Angeles.
Christoph D RauCardiovascular Laboratory, Division of Molecular Medicine, Department of Anesthesiology and Perioperative Medicine (J.H., J.Z.L., C.D.R., T.Y., T.K.K., C.G., Y.W.), University of California, Los Angeles.
Arash PezhoumanDivision of Cardiology, Department of Medicine (A.P., T.Y., R.A.), University of California, Los Angeles.ORCID 0000-0001-9106-7136
Tomohiro YokotaCardiovascular Laboratory, Division of Molecular Medicine, Department of Anesthesiology and Perioperative Medicine (J.H., J.Z.L., C.D.R., T.Y., T.K.K., C.G., Y.W.), University of California, Los Angeles.
Hiromi MiwaDepartment of Bioengineering, Samueli School of Engineering (H.M., S.U., D.D.), University of California, Los Angeles.
Matthew FeldmanSchool of Medicine, Meharry Medical College, Nashville, TN (M.F.).
Tsz Kin KongCardiovascular Laboratory, Division of Molecular Medicine, Department of Anesthesiology and Perioperative Medicine (J.H., J.Z.L., C.D.R., T.Y., T.K.K., C.G., Y.W.), University of California, Los Angeles.
Ziyue YangDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX (Z.Y.).
Woan Ting TaySignature Research Program of Cardiovascular and Metabolic Diseases, Duke-NUS Medical School, Singapore (W.T.T., Y.W.).ORCID 0000-0002-4845-287X
Ivan PushkarskyForcyte Biotechnologies, Inc, Los Angeles, CA (I.P.).
Kyungsoo KimVanderbilt Center for Arrhythmia Research and Therapeutics, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN (K.K., S.S.P., B.C.K.).ORCID 0000-0003-2869-0659
Shan S ParikhVanderbilt Center for Arrhythmia Research and Therapeutics, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN (K.K., S.S.P., B.C.K.).ORCID 0000-0003-1806-9199
Shreya UdaniSignature Research Program of Cardiovascular and Metabolic Diseases, Duke-NUS Medical School, Singapore (W.T.T., Y.W.).
Boon Seng SohInstitute of Molecular and Cell Biology, The Agency for Science, Technology and Research (A*STAR), Singapore (B.S.S.).ORCID 0000-0001-9134-3081
Chen GaoCardiovascular Laboratory, Division of Molecular Medicine, Department of Anesthesiology and Perioperative Medicine (J.H., J.Z.L., C.D.R., T.Y., T.K.K., C.G., Y.W.), University of California, Los Angeles.
Linsey StilesDepartment of Medicine, David Geffen School of Medicine (L.S., O.S.S.), University of California, Los Angeles.
Orian S ShirihaiDepartment of Medicine, David Geffen School of Medicine (L.S., O.S.S.), University of California, Los Angeles.
Bjorn C KnollmannVanderbilt Center for Arrhythmia Research and Therapeutics, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN (K.K., S.S.P., B.C.K.).ORCID 0000-0003-4956-9735
Reza ArdehaliDivision of Cardiology, Department of Medicine (A.P., T.Y., R.A.), University of California, Los Angeles.ORCID 0000-0003-1318-4016
Dino Di CarloDepartment of Bioengineering, Samueli School of Engineering (H.M., S.U., D.D.), University of California, Los Angeles.
Yibin WangCardiovascular Laboratory, Division of Molecular Medicine, Department of Anesthesiology and Perioperative Medicine (J.H., J.Z.L., C.D.R., T.Y., T.K.K., C.G., Y.W.), University of California, Los Angeles.ORCID 0000-0003-0852-0767
University of California, Los Angeles · USInstitute of Molecular Medicine · INVanderbilt University · USSamueli Institute · USSignature Research (United States) · USAgency for Science, Technology and Research · SGBaylor College of Medicine · USIncyte (United States) · USMeharry Medical College · USUniversity of North Carolina at Chapel Hill · US
Funding
Generation of mature human embryonic stem cell-derived left ventricular cardiomyocytes for transplantation in a large animal modelR01HL148714 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARDEHALI, REZA · 2019 to 2022
$2.2MNovel Mechanism of RBFox1 Mediated RNA Metabolism in Heart FailureR00HL141626 · NHLBI · UNIVERSITY OF CINCINNATI · PI GAO, CHEN · 2022 to 2024
$747kNHLBI NIH HHS R00 HL141626NHLBI NIH HHS R01 HL148714
Abstract
PubMed holds no abstract for this paper.
Indexed as
Myocytes, CardiacRNA SplicingAlternative SplicingHumansRNA Splicing FactorsRNA Splicing Factorsmyocytes, cardiacRNA, messengersequence analysis, RNA
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.